Amanda Cope
Primary Care · Harrison, ARNPI 1033661798
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by GSK at 33.2% of the total. 2025 is the largest year on record at $87, 7.3 times the $12 reported in 2021. That places this record below the midpoint for primary care clinicians in AR, where the typical reported total is $261.
Across 9 payments — averaging $28.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$87
- Medtronic$51
- Lexicon Pharmaceuticals, Inc.$32
- Boston Scientific$29
- Edwards Lifesciences$24
- Atricure, Inc.$14
- plus $24 from 2 others
What the payments were for
- Food & beverage$261100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 1 | $87 |
| Medtronic | 1 | $51 |
| Lexicon Pharmaceuticals, Inc. | 2 | $32 |
| Boston Scientific | 1 | $29 |
| Edwards Lifesciences | 1 | $24 |
| Atricure, Inc. | 1 | $14 |
| AstraZeneca | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$261 in reported general payments places this provider in the 50th percentile of 76 primary care providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 77 | $25,563 |
| JanuviaSitagliptin Phosphate | 50 | $24,217 |
| OzempicSemaglutide | 17 | $20,965 |
| MyrbetriqMirabegron | 39 | $16,831 |
| XareltoRivaroxaban | 16 | $9,230 |
| JardianceEmpagliflozin | 24 | $8,351 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 310 | $7,763 |
| Spiriva RespimatTiotropium Bromide | 11 | $5,821 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $4,293 |
| Potassium Chloride | 147 | $3,568 |
| LantusInsulin Glargine,hum.Rec.Anlog | 20 | $2,980 |
| Ventolin HfaAlbuterol Sulfate | 27 | $2,714 |
| Gabapentin | 196 | $2,631 |
| Trazodone Hcl | 224 | $2,343 |
| Cefdinir | 84 | $1,795 |
Paid to pharmacies, not to this prescriber.
Other primary care in Harrison
- Taesha WinfordHarrison$995
- Elisabeth BrownHarrison$290
- Hannah WilburnHarrison$255
- Andrew OliverMaumelle$45K
- Chelsea PressonLittle Rock$22K
- Stephen RohrerWynne$15K
- Chelsea MarquisSpringdale$12K
- Katherine ThompsonLittle Rock$10K
- Barbara ColeNorth Little Rock$9K
- Celeste WilliamsCenterton$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.